Literature DB >> 11083642

Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

C R DeLoney1, N L Schiller.   

Abstract

An amoxicillin-resistant (Amox(r)) strain of Helicobacter pylori was selected for by culturing an amoxicillin-sensitive (Amox(s)) strain in increasingly higher concentrations of amoxicillin, resulting in a 133-fold increase in MIC, from 0.03 to 0.06 microg/ml to 4 to 8 microg/ml. This resistance was stable upon freezing for at least 6 months and conferred cross-resistance to seven other beta-lactam antibiotics. beta-Lactamase activity was not detected in this Amox(r) strain; however, analysis of the penicillin-binding protein (PBP) profiles generated from isolated bacterial membranes of the Amox(s) parental strain and the Amox(r) strain revealed a significant decrease in labeling of PBP 1 by biotinylated amoxicillin (bio-Amox) in the Amox(r) strain. Comparative binding studies of PBP 1 for several beta-lactams demonstrated that PBP 1 in the Amox(r) strain had decreased affinity for mezlocillin but not significantly decreased affinity for penicillin G. In addition, PBP profiles prepared from whole bacterial cells showed decreased labeling of PBP 1 and PBP 2 in the Amox(r) strain at all bio-Amox concentrations tested, suggesting a diffusional barrier to bio-Amox or a possible antibiotic efflux mechanism. Uptake analysis of (14)C-labeled penicillin G showed a significant decrease in uptake of the labeled antibiotic by the Amox(r) strain compared to the Amox(s) strain, which was not affected by pretreatment with carbonyl cyanide m-chlorophenylhydrazone, eliminating the possibility of an efflux mechanism in the resistant strain. These results demonstrate that alterations in PBP 1 and in the uptake of beta-lactam antibiotics in H. pylori can be selected for by prolonged exposure to amoxicillin, resulting in increased resistance to this antibiotic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083642      PMCID: PMC90207          DOI: 10.1128/AAC.44.12.3368-3373.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Rifampin and rifabutin resistance mechanism in Helicobacter pylori.

Authors:  M Heep; D Beck; E Bayerdörffer; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  The complete genome sequence of the gastric pathogen Helicobacter pylori.

Authors:  J F Tomb; O White; A R Kerlavage; R A Clayton; G G Sutton; R D Fleischmann; K A Ketchum; H P Klenk; S Gill; B A Dougherty; K Nelson; J Quackenbush; L Zhou; E F Kirkness; S Peterson; B Loftus; D Richardson; R Dodson; H G Khalak; A Glodek; K McKenney; L M Fitzegerald; N Lee; M D Adams; E K Hickey; D E Berg; J D Gocayne; T R Utterback; J D Peterson; J M Kelley; M D Cotton; J M Weidman; C Fujii; C Bowman; L Watthey; E Wallin; W S Hayes; M Borodovsky; P D Karp; H O Smith; C M Fraser; J C Venter
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

3.  Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.

Authors:  F Ikeda; Y Yokota; Y Mine; M Tatsuta
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori.

Authors:  A G Harris; S L Hazell; A G Netting
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

Review 5.  Antimicrobial treatment of Helicobacter pylori infection.

Authors:  C S Goodwin
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori.

Authors:  Y J Debets-Ossenkopp; M Sparrius; J G Kusters; J J Kolkman; C M Vandenbroucke-Grauls
Journal:  FEMS Microbiol Lett       Date:  1996-08-15       Impact factor: 2.742

7.  Isolation and characterization of a conserved porin protein from Helicobacter pylori.

Authors:  P Doig; M M Exner; R E Hancock; T J Trust
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

8.  Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.

Authors:  C Neuwirth; E Siébor; J M Duez; A Péchinot; A Kazmierczak
Journal:  J Antimicrob Chemother       Date:  1995-08       Impact factor: 5.790

9.  Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori.

Authors:  M R Iovene; M Romano; A P Pilloni; B Giordano; F Montella; S Caliendo; M A Tufano
Journal:  Chemotherapy       Date:  1999 Jan-Feb       Impact factor: 2.544

10.  Use of biotinylated beta-lactams and chemiluminescence for study and purification of penicillin-binding proteins in bacteria.

Authors:  M Dargis; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

View more
  15 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.

Authors:  Shamsun Nahar; Asish K Mukhopadhyay; Rasel Khan; Mian Mashhud Ahmad; Simanti Datta; Santanu Chattopadhyay; Swapan Chandra Dhar; Shafiqul Alam Sarker; Lars Engstrand; Douglas E Berg; G Balakrish Nair; Motiur Rahman
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Resistance mechanisms in an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

Authors:  Edgie-Mark A Co; Neal L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

Authors:  Kathleen R Jones; Jeong-Heon Cha; D Scott Merrell
Journal:  Curr Drug ther       Date:  2008-09-01

6.  Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico.

Authors:  J Torres; M Camorlinga-Ponce; G Pérez-Pérez; A Madrazo-De la Garza; M Dehesa; G González-Valencia; O Muñoz
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates.

Authors:  Nadia N Qureshi; Dimitrios Morikis; Neal L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

8.  Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection.

Authors:  Ji-Hyun Shin; Mierha Yang; Seung Woo Nam; Jung Taik Kim; Na Hye Myung; Won-Gi Bang; Im Hwan Roe
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori.

Authors:  Dong H Kwon; M P Dore; J J Kim; M Kato; M Lee; J Y Wu; D Y Graham
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 10.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.